Health Catalyst has announced its decision to divest its Vitalware unit to Med-Metrix for $147 million, marking a strategic realignment towards its core operational focus.
The agreement allows Health Catalyst to exit the mid-revenue cycle financial software segment, enabling a sharper focus on its primary offerings in clinical and operational performance improvement technologies. The transaction is anticipated to close in 2026, pending regulatory approvals.
Vitalware, which generated approximately $37 million in revenue in fiscal year 2025, specializes in coding compliance and charge capture solutions. Following the sale, Health Catalyst plans to utilize the proceeds to eliminate its $160 million senior secured term loan, thereby enhancing its financial stability and reducing debt burdens.
This restructuring is expected to redirect Health Catalyst's resources and attention towards its healthcare data platform and AI initiatives, leveraging nearly two decades of clinical and operational data to drive improvements in healthcare delivery. Med-Metrix aims to integrate Vitalware's capabilities to bolster its own revenue cycle management services.
This divestiture reflects a broader trend in the healthcare technology sector, where companies are increasingly focusing on their core competencies to navigate a rapidly evolving landscape. By streamlining operations, Health Catalyst positions itself to better address the demands of healthcare analytics and artificial intelligence, potentially enhancing its competitive edge.